Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target

被引:122
|
作者
Chen, Jing [1 ]
Kos, Renate [1 ]
Garssen, Johan [1 ,2 ]
Redegeld, Frank [1 ]
机构
[1] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, NL-3508 TB Utrecht, Netherlands
[2] Danone Nutricia Res, Uppsalaan 12, NL-3584 CT Utrecht, Netherlands
关键词
necroptosis; MLKL; RIP kinase; necrosome; programmed cell death; cancer; inflammatory diseases; MIXED LINEAGE KINASE; INTERACTING PROTEIN-1 RIP1; DOMAIN-LIKE PROTEIN; CELL-DEATH; PSEUDOKINASE MLKL; MEDIATES NECROPTOSIS; PROGRAMMED NECROSIS; HIGHLY POTENT; ACTIVATION; APOPTOSIS;
D O I
10.3390/cells8121486
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Necroptosis, or regulated necrosis, is an important type of programmed cell death in addition to apoptosis. Necroptosis induction leads to cell membrane disruption, inflammation and vascularization. It plays important roles in various pathological processes, including neurodegeneration, inflammatory diseases, multiple cancers, and kidney injury. The molecular regulation of necroptotic pathway has been intensively studied in recent years. Necroptosis can be triggered by multiple stimuli and this pathway is regulated through activation of receptor-interacting protein kinase 1 (RIPK1), RIPK3 and pseudokinase mixed lineage kinase domain-like (MLKL). A better understanding of the mechanism of regulation of necroptosis will further aid to the development of novel drugs for necroptosis-associated human diseases. In this review, we focus on new insights in the regulatory machinery of necroptosis. We further discuss the role of necroptosis in different pathologies, its potential as a therapeutic target and the current status of clinical development of drugs interfering in the necroptotic pathway.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Vanilloid receptors: New insights enhance potential as a therapeutic target
    Szallasi, A
    Blumberg, PM
    PAIN, 1996, 68 (2-3) : 195 - 208
  • [22] Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target
    Cougnoux, A.
    Cluzeau, C.
    Mitra, S.
    Li, R.
    Williams, I.
    Burkert, K.
    Xu, X.
    Wassif, C. A.
    Zheng, W.
    Porter, F. D.
    CELL DEATH & DISEASE, 2016, 7 : e2147 - e2147
  • [23] Telomerase: A potential molecular marker and therapeutic target for cancer
    Chang, JY
    JOURNAL OF SURGICAL ONCOLOGY, 2004, 87 (01) : 1 - 3
  • [24] Molecular mechanism of asthma and its novel molecular target therapeutic agent
    Suraya, Ratoe
    Nagano, Tatsuya
    Katsurada, Masahiro
    Sekiya, Reina
    Kobayashi, Kazuyuki
    Nishimura, Yoshihiro
    RESPIRATORY INVESTIGATION, 2021, 59 (03) : 291 - 301
  • [25] Necroptosis inhibitors: mechanisms of action and therapeutic potential
    Yingbo Zhou
    Zhangtao Cai
    Yijia Zhai
    Jintao Yu
    Qiujing He
    Yuan He
    Siriporn Jitkaew
    Zhenyu Cai
    Apoptosis, 2024, 29 : 22 - 44
  • [26] Necroptosis inhibitors: mechanisms of action and therapeutic potential
    Zhou, Yingbo
    Cai, Zhangtao
    Zhai, Yijia
    Yu, Jintao
    He, Qiujing
    He, Yuan
    Jitkaew, Siriporn
    Cai, Zhenyu
    APOPTOSIS, 2024, 29 (1-2) : 22 - 44
  • [27] Necroptosis: Modules and molecular switches with therapeutic implications
    Arora, Deepika
    Sharma, Pradeep Kumar
    Siddiqui, Mohammed Haris
    Shukla, Yogeshwer
    BIOCHIMIE, 2017, 137 : 35 - 45
  • [28] Endothelial Dysfunction: From a Pathophysiological Mechanism to a Potential Therapeutic Target
    Ambrosino, Pasquale
    Grassi, Guido
    Maniscalco, Mauro
    BIOMEDICINES, 2022, 10 (01)
  • [29] TLR10: Insights, controversies and potential utility as a therapeutic target
    Su, Si-Biao
    Tao, Lin
    Deng, Ze-Ping
    Chen, Wen
    Qin, Shan-Yu
    Jiang, Hai-Xing
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, 93 (04)
  • [30] Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma
    Adachi, Mami
    Hoshino, Yuki
    Izumi, Yusuke
    Takagi, Satoshi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2016, 78 (04): : 649 - 656